Page last updated: 2024-10-22

albuterol and Non-communicable Chronic Diseases

albuterol has been researched along with Non-communicable Chronic Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bissell, K1
Perrin, C1
Beran, D1

Other Studies

1 other study available for albuterol and Non-communicable Chronic Diseases

ArticleYear
Access to essential medicines to treat chronic respiratory disease in low-income countries.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:6

    Topics: Albuterol; Anti-Asthmatic Agents; Beclomethasone; Burkina Faso; Chronic Disease; Developing Countrie

2016